Attune Revision Knee System
Depuy, Inc. · Decision date Sep 21, 2026
What did the FDA approve?
The FDA record lists approval of supplement P830055/S351 for DePuy, Inc.'s Attune Revision Knee System, filed under the Normal 180 Day Track with the reason Change Design/Components/Specifications/Material. Because the identifier ties this supplement to PMA P830055, it modifies that existing approval for the device category Prosthesis, knee, patellofemoral-tibial, semi-constrained, metal/polymer, mobile bearing; it is not an approval of a new device.
The statement covers two changes to the Attune Revision CRS Rotating Platform (CRS RP) tibial insert components: adding ram extrusion as an alternative to compression molding for the AOX UHMWPE bar stock material, and replacing single high-dose sterilization with a split-dose method combining raw-material crosslinking and final terminal sterilization. The record gives no test data, sterilization doses, or clinical or safety conclusions, and its stated purpose is not independent proof of safety or effectiveness.
FDA approval order statement
approval for the following two changes for the Attune Revision CRS Rotating Platform (CRS RP) tibial insert components of the Attune Revision Knee System:i. change in the manufacturing consolidation process to add ram extrusion as an alternative to compression molding for bar stock material antioxidant (Pentaerythritol tetrakis [3-(3,5-di-tert-butyl-4-hydroxyphenyl) propionate]) (AOX), Ultra-High Molecular Weight Polyethylene (UHMWPE) material of the aforementioned components.ii. change in sterilization dose from a single, high dose sterilization to a split-dose sterilization method through a combination of crosslinking AOX UHMWPE raw material and final terminal sterilization of the aforementioned components.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- Orthopedic
- Decision date
- Sep 21, 2026
- FDA change category
- Change Design/Components/Specifications/Material
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P830055/S351
- Regulatory pathway
- PMA supplement
- Applicant
- Depuy, Inc.
- Product code
- NJL
- Decision code
- APPR
- Decision date
- Sep 21, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing.
- Applicant
- Depuy, Inc.
- Product code
- NJL
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P830055/S351 received
Application receipt date recorded by FDA.
P830055/S374 · Related supplement
LCS(R) TOTAL KNEE SYSTEM, specifically ATTUNE Cruciate Retaining (CR), Posterior Stabilized (PS) and Revision Femoral C
P830055/S372 · Related supplement
ATTUNE Rotating Platform (RP) Total Knee System, ATTUNE Cementless Rotating Platform (RP) Knee System, ATTUNE Revision R
P830055/S376 · Related supplement
Attune Rotating Platform (RP) Total Knee System and the DePuy P.F.C. Sigma Rotating Platform (RP) Total Knee System an
P830055/S351 · FDA decision
Normal 180 Day Track
P830055/S375 · Related supplement
LCS Total Knee System
P830055/S380 · Related supplement
LCS Total Knee System
P830055/S377 · Related supplement
ATTUNE Rotating Platform (RP) Total Knee System, ATTUNE Revision Rotating Platform (RP) Total Knee System, and M.B.T. Re
P830055/S379 · Related supplement
ATTUNE Revision Knee System
P830055/S378 · Related supplement
LCS Knee System
P830055/S381 · Related supplement
ATTUNE Rotating Platform (RP) Total Knee System, and ATTUNE Revision Rotating Platform (RP) Knee System
Timeline entries are records held by MedtechLedger for P830055. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P830055
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Depuy, Inc. | PMA supplement | Sep 3, 2026 | FDA | |
| Depuy, Inc. | PMA supplement | Sep 9, 2026 | FDA | |
| Depuy, Inc. | PMA supplement | Sep 10, 2026 | FDA | |
LCS Total Knee SystemP830055/S375 | Depuy, Inc. | PMA supplement | Sep 25, 2026 | FDA |
LCS Total Knee SystemP830055/S380 | Depuy, Inc. | PMA supplement | Oct 5, 2026 | FDA |
| Depuy, Inc. | PMA supplement | Oct 8, 2026 | FDA | |
ATTUNE Revision Knee SystemP830055/S379 | Depuy, Inc. | PMA supplement | Oct 9, 2026 | FDA |
LCS Knee SystemP830055/S378 | Depuy, Inc. | PMA supplement | Oct 27, 2026 | FDA |
| Depuy, Inc. | PMA supplement | Oct 27, 2026 | FDA |
Explore the linked device profile
Other records with product code NJL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
NexGen LPS-Flex/LPS Mobile Bearing Knee SystemP060037/S100 | Zimmer, Inc. | PMA supplement | Oct 16, 2026 | FDA |
| Zimmer, Inc. | PMA supplement | Sep 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Depuy, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- P.O. Box 988, 700 Orthopaedic Dr., Warsaw, IN, 46581
Sources and methodology
- Original FDA record: P830055/S351
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





